Shilpa Medicare gets USFDA approval for Irinotecan HCL Injection; Stock gains 3%

According to IQVIA MAT Q2 2018 data, the US market for Irinotecan HCL is ~$18mn.

from India Infoline News Service http://bit.ly/2F1wW86